Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name Sort descending PI Organization Title Grant Number Program Official
Alexandrov, Ludmil B

University Of California, San Diego
United States

Mapping immuno-genomic drivers of the head and neck precancer invasive-disease transition 5U01CA290479-03 Wendy Wang, Ph.D., M.Sc.
Allen, Peter J

Duke University
United States

Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas 5R01CA182076-08 Matthew Young, Ph.D.
Amuta, Ann Oyare

University Of Texas Arlington
United States

Development of Tailored, Multilevel Cervical Cancer Interventions for Ethnically Diverse Black Women 1R15CA294297-01 Goli Samimi, Ph.D., M.P.H.
Anderson, Karen Sue

Arizona State University-Tempe Campus
United States

Southwest EDRN Clinical Validation Center for Head and Neck Cancer 5U01CA281660-03 Wendy Wang, Ph.D., M.Sc.
Anderson, Daniel M

Healthpartners Institute
United States

Metro-Minnesota Community Oncology Research Consortium (MMCORC) 3UG1CA189863-12S1 Vanessa A. White, M.P.H.
Anderson, Garnet L.

Fred Hutchinson Cancer Center
United States

NCI Cancer Screening Research Network: Coordinating and Communication Center 3UG1CA286954-02S1 Elyse LeeVan, M.D., M.P.H.
Arnold, Corey Wells

University Of California Los Angeles
United States

Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification 5R01CA279666-02 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Atigadda, Venkatram Reddy

University Of Alabama At Birmingham
United States

Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer 5R01CA276683-03
Backman, Vadim

Northwestern University At Chicago
United States

Optical hyperspectral nanoscale chromatin analysis for colon cancer risk-stratification 1R01CA289294-01A1 Claire Zhu, Ph.D.
Badve, Sunil S.

Emory University
United States

Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms 5R01CA281932-02 Wendy Wang, Ph.D., M.Sc.